1. Home
  2. HROW vs RAMP Comparison

HROW vs RAMP Comparison

Compare HROW & RAMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$46.15

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo LiveRamp Holdings Inc.

RAMP

LiveRamp Holdings Inc.

HOLD

Current Price

$37.57

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
RAMP
Founded
1998
2018
Country
United States
United States
Employees
373
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.7B
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
HROW
RAMP
Price
$46.15
$37.57
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$69.86
$35.60
AVG Volume (30 Days)
853.2K
1.2M
Earning Date
05-11-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
22500.00
EPS
N/A
2.24
Revenue
N/A
$812,940,000.00
Revenue This Year
$31.62
$11.18
Revenue Next Year
$50.77
$9.09
P/E Ratio
N/A
$16.76
Revenue Growth
N/A
9.03
52 Week Low
$28.54
$21.71
52 Week High
$54.98
$37.92

Technical Indicators

Market Signals
Indicator
HROW
RAMP
Relative Strength Index (RSI) 70.69 64.45
Support Level $44.30 $37.25
Resistance Level $51.01 $37.90
Average True Range (ATR) 2.20 0.20
MACD 0.36 -0.23
Stochastic Oscillator 91.44 54.92

Price Performance

Historical Comparison
HROW
RAMP

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

About RAMP LiveRamp Holdings Inc.

LiveRamp Holdings Inc is a technology company that helps companies build enduring brand and business value by collaborating responsibly with data. A groundbreaking leader in consumer privacy, data ethics, and foundational identity, LiveRamp offers a connected customer view with clarity and context while protecting brand and consumer trust. The Company provides a data collaboration platform, essentially acting as a data collaboration hub where businesses can securely share and manage first-party consumer data with trusted partners while prioritizing data privacy and ethics.

Share on Social Networks: